Skip to main content
SpringerLink
Log in

Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model

  • Dermal Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Protein kinase C (PKC) mediates a number of intracellular signal transduction pathways implicated in the pathogenesis of inflammation, including phospholipase A2-dependent arachidonic acid release and eicosanoid production. Recent studies demonstrate that the PKC inhibitor GF109203X significantly reduces a number of inflammatory processes resulting from PKC activation by the topical application of phorbol myristate acetate (PMA) to mouse ears. In this model, GF109203X significantly reduced edema at doses similar to the PKC inhibitor staurosporine, and more effectively than indomethacin, zileuton, or sodium meclofenamate. Histological and biochemical analysis of biopsies from control and drug-treated ears revealed a marked reduction in edema, infiltrating neutrophils, and levels of the neutrophil-specific marker, myeloperoxidase, in GF109203X-treated mice. Prostaglandin E2 levels were also reduced in ears treated with GF109203X. These data suggest that GF109203X is an effective antiinflammatory agent as evaluated in the PMA model of edema, and implicates PKC as a potential target in the development of novel anti-inflammatory agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Y. Nishizuka,Studies and prospectives of the protein kinase family for cellular regulation. Cancer63, 1892–1903 (1989).

    PubMed  Google Scholar 

  2. J. M. Young, B. M. Wagner and D. A. Spires,Tachyphylaxis in 12-O-tetradecanoylphorbolacetate- and arachidonic acid-induced ear edema. J. Invest. Dermatol.80, 48–52 (1983).

    Article  PubMed  Google Scholar 

  3. C. R. Loomis and R. M. Bell,Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J. Biol. Chem.263, 1682–1692 (1988).

    PubMed  Google Scholar 

  4. H. Hidaka, M. Inagaki, S. Kawamoto and I. Sasaki,Isoquinolinesulfonamides, novel and potent inhibitor of cyclic nucleotide-dependent protein kinase and protein kinase C. Biochemistry23, 5036–5041 (1984).

    Article  PubMed  Google Scholar 

  5. T. Tamaoki, H. Nomoto, I. Takahashi, Y. Kato, M. Morimoto and F. Tomita,Staurosporine, a potent inhibitor of phospholipid/Ca ++ dependent protein kinase. Biochem. Biophys. Res. Commun.135, 397–402 (1986).

    Article  PubMed  Google Scholar 

  6. D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Churon and J. Kirilousky,The bisindolylmaleimide GF109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem.266, 15771–15781 (1991).

    PubMed  Google Scholar 

  7. R. P. Carlson, L. O'Neill-Davis, J. Chang and A. Lewis,Modulation of mouse ear edema by cyclooxygenase and lipooxygenase inhibitors and other pharmacologic agents. Agents and Actions17, 198–204 (1985).

    Article  Google Scholar 

  8. R. R. Harris, W. M. Mackin, D. G. Batt, S. M. Rakich, R. J. Collins, E. M. Bruin and N. R. Ackerman,Cellular and biochemical characterization of the antiinflammatory effects of Dup 654 in the arachidonic acid murine skin inflammation model. Skin Pharmacol.3, 29–40 (1990).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, 48105, Ann Arbor, MI, USA

    S. Kuchera, H. Barth, P. Jacobson, A. Metz, C. Schaechtele & D. Schrier

Authors
  1. S. Kuchera
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Barth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Metz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Schaechtele
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Schrier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuchera, S., Barth, H., Jacobson, P. et al. Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model. Agents and Actions 39 (Suppl 1), C169–C173 (1993). https://doi.org/10.1007/BF01972756

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01972756

Keywords

Search

Navigation